Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.

Frontiers in immunology - 1 Jan 2021

Lindner Holger A, Velásquez Sonia Y, Thiel Manfred, Kirschning Thomas

Abstract excerpt

The pathological processes by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that make the virus a major threat to global health are insufficiently understood. Inefficient viral clearance at any stage is a hallmark of coronavirus disease 2019 (COVID-19). Disease severity is associated with increases in peripheral blood cytokines among which interleukin 10 (IL-10) increases particularly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to COVID-19
Share to COVID-19 Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-10

Share to SARS-CoV-2

Share to Severity of Illness Index

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 33746948
DOI: 10.3389/fimmu.2021.602130
PMCID: PMC7966717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.PMID 33746948Read ↗

IP-10 Predicts Clinical Progression and Response to IL-6 Blockade with Sarilumab in Early COVID-19 Pneumonia. The SARICOR Clinical TrialSemantic proximity Read ↗

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patientsSemantic proximity Read ↗

Cxcl10 is required for survival during SARS-CoV-2 infection in miceSemantic proximity Read ↗

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host-Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by <i>Betacoronavirus</i>Semantic proximity Read ↗

Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19Semantic proximity Read ↗

Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider.Semantic proximity Read ↗

Two distinct immunopathological profiles in lungs of lethal COVID-19Semantic proximity Read ↗

Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.